High throughput sequencing reveals the diversity of TRB-CDR3 repertoire in patients with psoriasis vulgaris

International Immunopharmacology

Volumn 40, Issue , 2016, Pages 487-491

  Cao, Xiaofang ^a   Wa, Qingbiao ^b   Wang, Qidi ^a   Li, Lin ^b   Liu, Xin ^a,c   An, Lisha ^a   Cai, Ruikun ^a   Du, Meng ^a,d   Qiu, Yue ^a,d   Han, Jian ^e   Wang, Chunlin ^a,f   Wang, Xingyu ^a,c   Guo, Changlong ^a   Lu, Yonghong ^b   Ma, Xu ^a,d  

^a NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

^b Department of Dermatovenereology Chengdu Second People s Hospital   (China)

^c Beijing Hypertension League Institute   (China)

^d GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

^e HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

High throughput sequencing; Psoriasis; TRB CDR3 repertoire

Indexed keywords

T LYMPHOCYTE RECEPTOR BETA CHAIN; COMPLEMENTARITY DETERMINING REGION; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE FRAGMENT;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; FEMALE; HIGH THROUGHPUT SEQUENCING; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PSORIASIS VULGARIS; GENETIC VARIATION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PSORIASIS; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; COMPLEMENTARITY DETERMINING REGIONS; FEMALE; GENES, T-CELL RECEPTOR BETA; GENETIC VARIATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PSORIASIS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84991687024     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2016.10.004     Document Type: Article

References (27)

1. [1] Bowcock, A.M., Krueger, J.G., Getting under the skin: the immunogenetics of psoriasis. Nat. Rev. Immunol. 5 (2005), 699–711.
2. [2] Cai, Y., Fleming, C., Yan, J., New insights of T cells in the pathogenesis of psoriasis. Cell Mol. Immunol. 9 (2012), 302–309.
3. [3] Christophers, E., Psoriasis—epidemiology and clinical spectrum. Clin. Exp. Dermatol. 26 (2001), 314–320.
4. [4] Mrowietz, U., Kragballe, K., Reich, K., Spuls, P., Griffiths, C.E., Nast, A., Franke, J., Antoniou, C., Arenberger, P., Balieva, F., Bylaite, M., Correia, O., Dauden, E., Gisondi, P., Iversen, L., Kemeny, L., Lahfa, M., Nijsten, T., Rantanen, T., Reich, A., Rosenbach, T., Segaert, S., Smith, C., Talme, T., Volc-Platzer, B., Yawalkar, N., Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch. Dermatol. Res. 303 (2011), 1–10.
5. [5] Myers, W.A., Gottlieb, A.B., Mease, P., Psoriasis and psoriatic arthritis: clinical features and disease mechanisms. Clin. Dermatol. 24 (2006), 438–447.
6. [6] Lin, Y., Zhao, P., Shen, C., Shen, S., Zheng, X., Zuo, X., Yang, S., Zhang, X., Yin, X., Identification of cell types, tissues and pathways affected by risk loci in psoriasis. Mol. Gen. Genomics. 291 (2016), 1005–1012.
7. [7] Ghoreschi, K., Weigert, C., Rocken, M., Immunopathogenesis and role of T cells in psoriasis. Clin. Dermatol. 25 (2007), 574–580.
8. [8] Jariwala, S.P., The role of dendritic cells in the immunopathogenesis of psoriasis. Arch. Dermatol. Res. 299 (2007), 359–366.
9. [9] Lowes, M.A., Suarez-Farinas, M., Krueger, J.G., Immunology of psoriasis. Annu. Rev. Immunol. 32 (2014), 227–255.
10. [10] Chaudhari, U., Romano, P., Mulcahy, L.D., Dooley, L.T., Baker, D.G., Gottlieb, A.B., Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet 357 (2001), 1842–1847.
11. [11] Harden, J.L., Hamm, D., Gulati, N., Lowes, M.A., Krueger, J.G., Deep sequencing of the T-cell receptor repertoire demonstrates polyclonal T-cell infiltrates in psoriasis. F1000Res, 4, 2015, 460.
12. [12] Telfer, N.R., Chalmers, R.J., Whale, K., Colman, G., The role of streptococcal infection in the initiation of guttate psoriasis. Arch. Dermatol. 128 (1992), 39–42.
13. [13] Sigurdardottir, S.L., Thorleifsdottir, R.H., Valdimarsson, H., Johnston, A., The association of sore throat and psoriasis might be explained by histologically distinctive tonsils and increased expression of skin-homing molecules by tonsil T cells. Clin. Exp. Immunol. 174 (2013), 139–151.
14. [14] Sigurdardottir, S.L., Thorleifsdottir, R.H., Valdimarsson, H., Johnston, A., The role of the palatine tonsils in the pathogenesis and treatment of psoriasis. Br. J. Dermatol. 168 (2013), 237–242.
15. [15] Menssen, A., Trommler, P., Vollmer, S., Schendel, D., Albert, E., Gurtler, L., Riethmuller, G., Prinz, J.C., Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris. J. Immunol. 155 (1995), 4078–4083.
16. [16] Besgen, P., Trommler, P., Vollmer, S., Prinz, J.C., Ezrin, maspin, peroxiredoxin 2, and heat shock protein 27: potential targets of a streptococcal-induced autoimmune response in psoriasis. J. Immunol. 184 (2010), 5392–5402.
17. [17] Karczewski, J., Dobrowolska, A., Rychlewska-Hanczewska, A., Adamski, Z., New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis. Autoimmunity, 1-16, 2016.
18. [18] Lande, R., Botti, E., Jandus, C., Dojcinovic, D., Fanelli, G., Conrad, C., Chamilos, G., Feldmeyer, L., Marinari, B., Chon, S., Vence, L., Riccieri, V., Guillaume, P., Navarini, A.A., Romero, P., Costanzo, A., Piccolella, E., Gilliet, M., Frasca, L., The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis. Nat. Commun., 5, 2014, 5621.
19. [19] Saraceno, R., Kleyn, C.E., Terenghi, G., Griffiths, C.E., The role of neuropeptides in psoriasis. Br. J. Dermatol. 155 (2006), 876–882.
20. [20] Robins, H., Immunosequencing: applications of immune repertoire deep sequencing. Curr. Opin. Immunol. 25 (2013), 646–652.
21. [21] Dziubianau, M., Hecht, J., Kuchenbecker, L., Sattler, A., Stervbo, U., Rodelsperger, C., Nickel, P., Neumann, A.U., Robinson, P.N., Mundlos, S., Volk, H.D., Thiel, A., Reinke, P., Babel, N., TCR repertoire analysis by next generation sequencing allows complex differential diagnosis of T cell-related pathology. Am. J. Transplant. 13 (2013), 2842–2854.
22. [22] Wang, C., Sanders, C.M., Yang, Q., Schroeder, H.W. Jr., Wang, E., Babrzadeh, F., Gharizadeh, B., Myers, R.M., Hudson, J.R. Jr., Davis, R.W., Han, J., High throughput sequencing reveals a complex pattern of dynamic interrelationships among human T cell subsets. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 1518–1523.
23. [23] Lefranc, M.P., IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 31 (2003), 307–310.
24. [24] Rechavi, E., Lev, A., Lee, Y.N., Simon, A.J., Yinon, Y., Lipitz, S., Amariglio, N., Weisz, B., Notarangelo, L.D., Somech, R., Timely and spatially regulated maturation of B and T cell repertoire during human fetal development. Sci. Transl. Med., 7, 2015, 276ra25.
25. [25] Prabakaran, P., Chen, W., Singarayan, M.G., Stewart, C.C., Streaker, E., Feng, Y., Dimitrov, D.S., Expressed antibody repertoires in human cord blood cells: 454 sequencing and IMGT/HighV-QUEST analysis of germline gene usage, junctional diversity, and somatic mutations. Immunogenetics 64 (2012), 337–350.
26. [26] Jackson, K.J., Kidd, M.J., Wang, Y., Collins, A.M., The shape of the lymphocyte receptor repertoire: lessons from the B cell receptor. Front. Immunol., 4, 2013, 263.
27. [27] Chang, J.C., Smith, L.R., Froning, K.J., Schwabe, B.J., Laxer, J.A., Caralli, L.L., Kurkland, H.H., Karasek, M.A., Wilkinson, D.I., Carlo, D.J., et al. CD8 + T-cells in psoriatic lesions preferentially use T-cell receptors V beta 3 and/or V beta 13.1 genes. Ann. N. Y. Acad. Sci. 756 (1995), 370–381.